Teva is the world’s leading authority on the API side of the pharmaceutical business. I doubt that their Lovenox non-approval relates to deficiencies in the supply chain.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”